H1N1 Vaccine Recalled in Canda After Severe Side-Effects

Doctors have been advised to stop giving the H1N1 Vaccine in Canda after an unusually high number of reactions in patients occurred.

The reactions range from skin rashes, elevated heart rates, and dyspnea (difficulty breathing). About 1 in 20,000 people have had various anaphylactic reaction to the vaccine which is made by GlaxoSmithKline.

172,000 doses of SmiGlaxothKline's Aperanix vaccine are being recalled and the company has asked doctors to stop giving the vaccine to patients.

The company has declined to say at this time how many people have been given the vaccine at this time.